Consortium Costs Debated As BARDA, Industry Discuss Plans For Next Pandemic Response

 
• By Bowman Cox

BARDA’s consortium approach scrutinized as industry recovers from US Defense Production Act rated orders. Questions of sustainment fees, interruptible commercial activities explored during BioMaC Industry Day call as agency emphasizes need for proven capacity.

Empty vials on manufacturing line
who will pay to prepare for the next surge? • Source: Alamy

More from Manufacturing

More from Compliance